1.94
price down icon1.02%   -0.02
after-market Handel nachbörslich: 1.93 -0.01 -0.52%
loading

Quince Therapeutics Inc Aktie (QNCX) Neueste Nachrichten

pulisher
07:14 AM

Is Quince Therapeutics Inc. stock a good choice for value investorsBear Alert & Daily Market Momentum Tracking - newser.com

07:14 AM
pulisher
03:23 AM

How to forecast Quince Therapeutics Inc. trends using time seriesTrade Risk Summary & Community Shared Stock Ideas - newser.com

03:23 AM
pulisher
Oct 13, 2025

What hedge fund activity signals for Quince Therapeutics Inc. stockMarket Movement Recap & Risk Controlled Stock Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Will Quince Therapeutics Inc. stock deliver shareholder valueJuly 2025 Snapshot & AI Powered Trade Plan Recommendations - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Is Quince Therapeutics Inc. trending in predictive chart models2025 Risk Factors & AI Enhanced Trade Execution Alerts - newser.com

Oct 13, 2025
pulisher
Oct 10, 2025

Quince Therapeutics Inc. stock daily chart insightsMarket Risk Report & Fast Moving Stock Watchlists - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Quince Therapeutics' (QNCX) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 09, 2025

Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Tel - PharmiWeb.com

Oct 09, 2025
pulisher
Oct 09, 2025

Quince Therapeutics presents A-T walking capacity data at neurology meeting By Investing.com - Investing.com Canada

Oct 09, 2025
pulisher
Oct 09, 2025

Quince Therapeutics (QNCX) Highlights Walking Study at Neurology Meeting - GuruFocus

Oct 09, 2025
pulisher
Oct 09, 2025

Quince Therapeutics presents A-T walking capacity data at neurology meeting - Investing.com

Oct 09, 2025
pulisher
Oct 09, 2025

Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting - Business Wire

Oct 09, 2025
pulisher
Oct 09, 2025

Quince Therapeutics Inc. stock outlook for YEAREarnings Risk Summary & Free High Return Stock Watch Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Visual trend scoring systems applied to Quince Therapeutics Inc.Risk Management & Real-Time Volume Analysis Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Has Quince Therapeutics Inc. formed a bullish divergenceEarnings Overview Report & High Return Stock Watch Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Can Quince Therapeutics Inc. stock hit analyst price targetsJuly 2025 Breakouts & Expert Verified Stock Movement Alerts - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

Analysts Set Quince Therapeutics, Inc. (NASDAQ:QNCX) PT at $8.14 - Defense World

Oct 07, 2025
pulisher
Oct 07, 2025

Is Quince Therapeutics (NASDAQ:QNCX) Using Too Much Debt? - simplywall.st

Oct 07, 2025
pulisher
Oct 07, 2025

What drives Quince Therapeutics Inc stock priceFinancial Sector Performance & Minimal Investment Capital - earlytimes.in

Oct 07, 2025
pulisher
Oct 05, 2025

Will Quince Therapeutics Inc. bounce back from current supportWatch List & Reliable Price Breakout Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Applying Wyckoff theory to Quince Therapeutics Inc. stock2025 AllTime Highs & Daily Chart Pattern Signals - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Applying Elliott Wave Theory to Quince Therapeutics Inc.Recession Risk & Verified Momentum Watchlists - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

Oppenheimer Sticks to Their Buy Rating for Quince Therapeutics (QNCX) - The Globe and Mail

Oct 04, 2025
pulisher
Oct 04, 2025

Oppenheimer Maintains Quince Therapeutics(QNCX.US) With Buy Rating, Maintains Target Price $10 - 富途牛牛

Oct 04, 2025
pulisher
Oct 03, 2025

Chart based analysis of Quince Therapeutics Inc. trendsJuly 2025 Volume & Real-Time Stock Price Movement Reports - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Quince Therapeutics stock maintains Market Outperform rating at Citizens - Investing.com

Oct 03, 2025
pulisher
Oct 02, 2025

Aqua Metals files to sell 1M shares of common stock for holders - MSN

Oct 02, 2025
pulisher
Oct 02, 2025

Transcript : Quince Therapeutics, Inc.Analyst/Investor Day - MarketScreener

Oct 02, 2025
pulisher
Oct 01, 2025

Quince Therapeutics (NASDAQ:QNCX) Stock Price Up 1.2% – Time to Buy? - Defense World

Oct 01, 2025
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):